Sepsis patients present with several symptoms ranging from tremors, fever, to severe confusion. However, the most critical indication of sepsis is sudden and significant drop in blood pressure, leading to incidence of septic shock and consequent organ failure. Sepsis is one of the prime causes of in-hospital mortality and also ranks among the most cost-intensive conditions being treated in hospitals worldwide.
Despite its humongous prevalence, sepsis treatment remains an object of speculation in several ways. Sepsis is termed as a syndrome and not a single disease, thus exhibiting as a collection of several causes and effects on patients. As the clinical understanding sepsis is advancing, the definition and diagnosis methods of sepsis are also correspondingly changing. Furthermore, being an expensive condition to treat, healthcare providers worldwide are emphasizing on earliest detection of sepsis and establishment of a standard guideline for intervention.
The scope of this report on" "sepsis diagnostics market" "offers detailed analysis of the market based on diagnosis products, technologies and geographical segmentation. Based on product types, the global sepsis diagnostics market is studied for blood culture media, assay kits and reagents and instruments. Molecular diagnostics, microbiology, immunoassays, and flow cytometry are the technologies that are employed for efficient diagnosis of sepsis.
Based on geographical demarcation of the globe, the sepsis diagnostics market is studied for North America (comprising United States and Canada), Europe (studied for United Kingdom, Germany and Rest of Europe), Asia Pacific (cumulative to China, Japan and Rest of Asia Pacific), Latin America (including Brazil, Mexico and Rest of Latin America), and Middle East and Africa (GCC and Rest of Europe). Market size and forecast is also presented for each regional and country-level market for the considered analysis period.
This report also analyzes the global market with the perspective of currently prevalent drivers and restraining factors. Future opportunities to be harnessed are also discussed in this study. The report also studied the competitive landscape of the major market players for the year 2020. Attractive investment proposition is also presented in this study to suggest the most prominent regional market eligible for proliferation, focus and corresponding investment. This report concludes with profiles of major players enjoying prominent position in the global sepsis diagnostics market.
Sepsis is one the most common causes of the death in hospitals. It is projected that sepsis diagnostics market will show prominent market growth during the forecast period due to significant growth in the number of sepsis patients emerging from rise in the number of surgeries, hospital-acquired infections, and technological advancement in sepsis management. Early detection is eminently needed for the improved outcome of treatment to patients affected with sepsis. It is studied that in the recent years, blood culture media has been the largest revenue contributing segment because it remains the gold standard detection method in microbiological diagnosis of sepsis due to its sensitivity and specificity. A number of advancements are made in blood culture media, such as development in enriched growth media, software for faster detection, etc. Despite these technological advancements, blood culture remains a time consuming method. Moreover, risk of false negative results due to the inhibitory effects of fastidious pathogens and antibiotics also limits the use of blood culture media.
It is anticipated that assay kits will show lucrative market growth during the forecast period due to rising adoption of assay kits, faster detection method, and growing approval for assay kits. Although there are number of manufacturers present in market, the assay kits and reagent market is currently dominated by, Thermo Fisher Scientific, Roche Diagnostics, T2 Biosystems, Bruker Corporation etc.
Despite the advancement in healthcare system, mortality related to sepsis remains high; accurate diagnosis is significant for correct identification of sepsis causing pathogens. At present, molecular diagnostic techniques are emerging and it is expected to show the highest market growth over the forecast period, as it is a rapid and accurate process over the conventional method. Previously, microbiology detection technique is widely accepted detection technique but due to more time consumption and increase in chance of false negative result demand for molecular diagnostics increase in market.
Molecular diagnostics techniques allows rapid detection of pathogen involved in sepsis. Furthermore, advancement in nucleic acid extraction and amplification would further assist the growth of molecular diagnostics segment globally. Technological advancements in molecular diagnostics, higher sensitivity, specificity, ability to detect fastidious or slow-growing organisms, reduced inhibitory effect of antibiotic and lesser turnaround time would drive the growth of molecular diagnostics market during the forecast period. On the other hand, some factors such as, risk of false positive results due to presence of contamination, lack of reference standard for laboratory standardization process and unfeasibility for recovery of live bacterial strain for additional diagnostic tests may negatively impact the growth of molecular diagnostics segment.
According to Centers for Disease Control and Prevention (CDC), one in every three patients who die in hospital have sepsis. As reported in JAMA study, 1.7 million hospitalizations and 270,000 deaths in the United States alone were accounted to sepsis. United States is the largest market for sepsis diagnostics. Dominance of United States and therefore North America market is due to phenomenal incidence of sepsis in hospitalization, significant costs and eminent high risk of mortality, thus prompting the need for early diagnosis. On the other hand, countries such as India, China, Philippines and Australia will collectively render rapid growth to the Asia Pacific sepsis diagnostics market. Rapid growth of healthcare system, growing ease in availability of novel diagnostic and screening methods and perpetual rise in incidence of sepsis.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Despite its humongous prevalence, sepsis treatment remains an object of speculation in several ways. Sepsis is termed as a syndrome and not a single disease, thus exhibiting as a collection of several causes and effects on patients. As the clinical understanding sepsis is advancing, the definition and diagnosis methods of sepsis are also correspondingly changing. Furthermore, being an expensive condition to treat, healthcare providers worldwide are emphasizing on earliest detection of sepsis and establishment of a standard guideline for intervention.
The scope of this report on" "sepsis diagnostics market" "offers detailed analysis of the market based on diagnosis products, technologies and geographical segmentation. Based on product types, the global sepsis diagnostics market is studied for blood culture media, assay kits and reagents and instruments. Molecular diagnostics, microbiology, immunoassays, and flow cytometry are the technologies that are employed for efficient diagnosis of sepsis.
Based on geographical demarcation of the globe, the sepsis diagnostics market is studied for North America (comprising United States and Canada), Europe (studied for United Kingdom, Germany and Rest of Europe), Asia Pacific (cumulative to China, Japan and Rest of Asia Pacific), Latin America (including Brazil, Mexico and Rest of Latin America), and Middle East and Africa (GCC and Rest of Europe). Market size and forecast is also presented for each regional and country-level market for the considered analysis period.
This report also analyzes the global market with the perspective of currently prevalent drivers and restraining factors. Future opportunities to be harnessed are also discussed in this study. The report also studied the competitive landscape of the major market players for the year 2020. Attractive investment proposition is also presented in this study to suggest the most prominent regional market eligible for proliferation, focus and corresponding investment. This report concludes with profiles of major players enjoying prominent position in the global sepsis diagnostics market.
Sepsis is one the most common causes of the death in hospitals. It is projected that sepsis diagnostics market will show prominent market growth during the forecast period due to significant growth in the number of sepsis patients emerging from rise in the number of surgeries, hospital-acquired infections, and technological advancement in sepsis management. Early detection is eminently needed for the improved outcome of treatment to patients affected with sepsis. It is studied that in the recent years, blood culture media has been the largest revenue contributing segment because it remains the gold standard detection method in microbiological diagnosis of sepsis due to its sensitivity and specificity. A number of advancements are made in blood culture media, such as development in enriched growth media, software for faster detection, etc. Despite these technological advancements, blood culture remains a time consuming method. Moreover, risk of false negative results due to the inhibitory effects of fastidious pathogens and antibiotics also limits the use of blood culture media.
It is anticipated that assay kits will show lucrative market growth during the forecast period due to rising adoption of assay kits, faster detection method, and growing approval for assay kits. Although there are number of manufacturers present in market, the assay kits and reagent market is currently dominated by, Thermo Fisher Scientific, Roche Diagnostics, T2 Biosystems, Bruker Corporation etc.
Despite the advancement in healthcare system, mortality related to sepsis remains high; accurate diagnosis is significant for correct identification of sepsis causing pathogens. At present, molecular diagnostic techniques are emerging and it is expected to show the highest market growth over the forecast period, as it is a rapid and accurate process over the conventional method. Previously, microbiology detection technique is widely accepted detection technique but due to more time consumption and increase in chance of false negative result demand for molecular diagnostics increase in market.
Molecular diagnostics techniques allows rapid detection of pathogen involved in sepsis. Furthermore, advancement in nucleic acid extraction and amplification would further assist the growth of molecular diagnostics segment globally. Technological advancements in molecular diagnostics, higher sensitivity, specificity, ability to detect fastidious or slow-growing organisms, reduced inhibitory effect of antibiotic and lesser turnaround time would drive the growth of molecular diagnostics market during the forecast period. On the other hand, some factors such as, risk of false positive results due to presence of contamination, lack of reference standard for laboratory standardization process and unfeasibility for recovery of live bacterial strain for additional diagnostic tests may negatively impact the growth of molecular diagnostics segment.
According to Centers for Disease Control and Prevention (CDC), one in every three patients who die in hospital have sepsis. As reported in JAMA study, 1.7 million hospitalizations and 270,000 deaths in the United States alone were accounted to sepsis. United States is the largest market for sepsis diagnostics. Dominance of United States and therefore North America market is due to phenomenal incidence of sepsis in hospitalization, significant costs and eminent high risk of mortality, thus prompting the need for early diagnosis. On the other hand, countries such as India, China, Philippines and Australia will collectively render rapid growth to the Asia Pacific sepsis diagnostics market. Rapid growth of healthcare system, growing ease in availability of novel diagnostic and screening methods and perpetual rise in incidence of sepsis.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Sepsis Diagnostics market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Sepsis Diagnostics market and their expected impact during the forecast period.
Market Segmentation
Product
- Blood Culture Media
- Assay Kits and Reagents
- Instruments
Technology
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Sepsis Diagnostics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Sepsis Diagnostics market?
- Which is the largest regional market for Sepsis Diagnostics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Sepsis Diagnostics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Sepsis Diagnostics market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Sepsis Diagnostics Market: Business Outlook & Market Dynamics
4. Sepsis Diagnostics Market: By Product, 2020-2030, USD (Million)
5. Sepsis Diagnostics Market: By Technology, 2020-2030, USD (Million)
6. North America Sepsis Diagnostics Market, 2020-2030, USD (Million)
7. UK and European Union Sepsis Diagnostics Market, 2020-2030, USD (Million)
8. Asia Pacific Sepsis Diagnostics Market, 2020-2030, USD (Million)
9. Latin America Sepsis Diagnostics Market, 2020-2030, USD (Million)
10. Middle East and Africa Sepsis Diagnostics Market, 2020-2030, USD (Million)
11. Company Profile
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories Inc.
- Becton
- Dickinson and Company
- Biomerieux Inc.
- Bruker Corporation
- Cepheid Inc.
- Immunexpress Inc.
- Nanosphere Inc. (A Luminex Company)
- Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
- T2 Biosystems Inc.
- Thermo Fisher Scientific Inc.
